ARCT Operating Cash Flow (Statement)
Arcturus Therapeutics Holdings Inc · Operating Cash Flow (Statement)
ARCT Operating Cash Flow (Statement)
Latest reported-$72.73Mperiod ending
ARCT TTM Cash from Operations (-$7.30M → -$72.73M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ARCT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -72,729,000 | |
| -58,574,000 | |
| -74,271,000 | |
| -58,328,000 | |
| -64,941,000 | |
| -89,328,000 | |
| -59,747,000 | |
| -60,092,000 | |
| -68,734,000 | |
| 12,215,000 | |
| -18,099,000 | |
| 142,789,000 | |
| 132,789,000 | |
| 45,161,000 | |
| 31,993,000 | |
| -170,763,000 | |
| -145,010,000 | |
| -141,132,000 | |
| -135,043,000 | |
| -99,178,000 | |
| -98,402,000 | |
| -73,953,000 | |
| -42,861,000 | |
| -43,767,000 | |
| -30,726,000 | |
| -12,892,000 | |
| -6,445,000 | |
| -4,670,000 | |
| -8,629,000 | |
| -25,810,000 | |
| -20,760,000 | |
| -5,123,000 | |
| 338,000 | |
| 4,143,000 | |
| -460,000 | |
| -14,357,000 | |
| -19,698,000 | |
| -19,768,000 | |
| -19,241,000 | |
| -19,497,000 | |
| -18,205,000 | |
| -17,990,000 | |
| -18,148,000 | |
| -21,610,000 | |
| -25,718,000 | |
| -27,295,000 | |
| -28,328,000 | |
| -25,367,000 | |
| -17,868,000 | |
| -12,749,000 | |
| -7,302,000 | |
| -2,791,000 | |
| -1,129,000 | |
| -1,087,000 |